The renowned brand of injected clogs, based in the United States, announced that it expects to end its 2022 balance sheet reaching a record revenue figure of US$ 3.55 billion, which represents an increase of 53% compared to the same period in 2021.
Recall that since the pandemic, CROCS products grew remarkably in demand, due to the comfort and functionality they offered to consumers.
Executive director Andrew Rees said 2022 was a banner year for CROCS with strong sales growth around the world. He also pointed out that the results have to do with the payment and reduction of loans for approximately US $ 500 million. The non-GAAP operating margin of the company during 2022 would be around 27%.
For the current fiscal year 2023, CROCS anticipates revenue growth of 10-13%, compared to 2022, which would give an annual figure of between US$ 3.9 and US$ 4 billion.
Source: World Footwear
RELATED ARTICLE:
- New launch of BALENCIAGA + CROC´S
Participate with your content in SERMA.NET
and in our printed edition.
It is the opportunity to reach your customers!
Write us! marketing@serma.net